5-Methylsalicylic acid → N-{2,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methylbenzamide

HRID 421149

반응식

HRID 421149 반응식
[CH3:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[CH3:12][C:13]([C:16]1[CH:22]=[CH:21][C:20]([C:23]([CH3:26])([CH3:25])[CH3:24])=[CH:19][C:17]=1[NH2:18])([CH3:15])[CH3:14]>>[CH3:15][C:13]([C:16]1[CH:22]=[CH:21][C:20]([C:23]([CH3:26])([CH3:25])[CH3:24])=[CH:19][C:17]=1[NH:18][C:7](=[O:9])[C:6]1[CH:10]=[C:2]([CH3:1])[CH:3]=[CH:4][C:5]=1[OH:11])([CH3:12])[CH3:14]

참가 물질

3

반응물 2

HCID 69735-Methylsalicylic acidHCID 6054882,5-di-tert-Butylaniline

생성물 1

HCID 66657221N-{2,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methylbenzamide수율 61.1%

실험 절차

Using 5-methylsalicylic acid and 2,5-bis[(1,1-dimethyl)ethyl]aniline as the raw materials, the same operation as the example 16 gave the title compound.

출처 및 근거

ORD 기록
ord-a08f8c1ceafd407ab2e8857141b9045d
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08097759B2

연결된 노트

불러오는 중…